Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma-Reference-Cited by-同舟云学术

Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma

Published:2014-05-28 Issue:11 Volume:41 Page:2031-2041
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Sato Jun,Kitagawa Yoshimasa,Yamazaki Yutaka,Hata Hironobu,Asaka Takuya,Miyakoshi Masaaki,Okamoto Shozo,Shiga Tohru,Shindoh Masanobu,Kuge Yuji,Tamaki Nagara

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-014-2810-y.pdf

Reference55 articles.

1. Wang W, Lee NY, Georgi JC, Narayanan M, Guillem J, Schöder H, et al. Pharmacokinetic analysis of hypoxia 18F-fluoromisonidazole dynamic PET in head and neck cancer. J Nucl Med. 2010;51:37–45.

2. Janssen HL, Haustermans KM, Balm AJ, Begg AC. Hypoxia in head and neck cancer: How much, how important? Head Neck. 2005;27:622–38.

3. Roh JL, Cho KJ, Kwon GY, Ryu CH, Chang HW, Choi SH, et al. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncol. 2009;45:63–8.

4. Yamane T, Kikuchi M, Shinohara S, Senda M. Reduction of [18F]-Fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma. Mol Imaging Biol. 2011;13:227–31.

5. Miyagaki H, Yamasaki M, Miyata H, Takahashi T, Kurokawa Y, Nakajima K, et al. Overexpression of PETK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma. Br J Cancer. 2012;106:947–54.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular imaging of tumor hypoxia: Evolution of nitroimidazole radiopharmaceuticals and insights for future development;Bioorganic Chemistry;2023-10

2. The imaging of the hypoxic microenvironment in tumorous tissue using PET/CT and PET/MRI;European Journal of Radiology;2022-09

3. Potential novel imaging targets of inflammation in cardiac sarcoidosis;Journal of Nuclear Cardiology;2021-11-03

4. Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET;Frontiers in Oncology;2021-09-07

5. Novel PET Tracers in the Management of Cardiac Sarcoidosis;Current Radiopharmaceuticals;2021-08-17